Prediction of the skin sensitization potential of didecyldimethylammonium chloride and 3,7-dimethyl-2,6-octadienal and mixtures of these compounds with the excipient ethylene glycol through the human Cell Line Activation Test and the Direct Peptide Reactivity Assay
Restricted accessResearch articleFirst published online August, 2019
Prediction of the skin sensitization potential of didecyldimethylammonium chloride and 3,7-dimethyl-2,6-octadienal and mixtures of these compounds with the excipient ethylene glycol through the human Cell Line Activation Test and the Direct Peptide Reactivity Assay
In commercial products such as household deodorants or biocides, didecyldimethylammonium chloride (DDAC) often serves as an antimicrobial agent, citral serves as a fragrance agent, and the excipient ethylene glycol (EG) is used to dissolve the active ingredients. The skin sensitization (SS) potentials of each of these substances are still being debated. Moreover, mixtures of DDAC or citral with EG have not been evaluated for SS potency. The in vitro alternative assay called human Cell Line Activation Test (h-CLAT) and Direct Peptide Reactivity Assay (DPRA) served to address these issues. On three independent runs of h-CLAT, DDAC and citral were predicted to be sensitizers while EG was predicted to be a non-sensitizer and also by the DPRA. Mixtures of DDAC or citral with EG at ratios of 7:3 and 1:4 w/v were all positive by the h-CLAT in terms of SS potential but SS potency was mitigated as the proportion of EG increased. Citral and its EG mixtures were all positive but DDAC and its EG mixtures were all negative by the DPRA, indicating that the DPRA method is not suitable for chemicals with pro-hapten characteristics. Since humans can be occupationally or environmentally exposed to mixtures of excipients with active ingredients, the present study may give insights into further investigations of the SS potentials of various chemical mixtures.
AndersonSEMeadeBJ (2014) Potential health effects associated with dermal exposure to occupational chemicals. Environmental Health Insights8(S1): 51–62.
2.
AndersonSEShaneHLongC, et al. (2016) Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride. Journal of Immunotoxicology13: 557–566.
3.
AngrishMMPleilJDStiegelMA, et al. (2016) Taxonomic applicability of inflammatory cytokines in adverse outcome pathway (AOP) development. Journal of Toxicology and Environmental Health A79: 184–196.
4.
AshikagaTYoshidaYHirotaM, et al. (2006) Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT) I. Optimization of the h-CLAT protocol. Toxicology in Vitro20: 767–773.
5.
ATSDR (2010) Toxicological Profile for Ethylene Glycol. Atlanta: US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry.
6.
BasketterDAClappCJefferiesD, et al. (2005) Predictive identification of human skin sensitization thresholds. Contact Dermatitis53: 260–267.
7.
BernsteinJAStauderTBernsteinDI, et al. (1994) A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines. Journal of Allergy and Clinical Immunology94: 257–259.
ClewellHJYagerJWGreeneTB, et al. (2018) Application of the adverse outcome pathway (AOP) approach to inform mode of action (MOA): a case study with inorganic arsenic. Journal of Toxicology and Environmental Health A81: 893–912.
10.
CoeckeSBallsMBoweG, et al. (2005) Guidance on good cell culture practice: a report of the second ECVAM task force on good cell culture practice. Alternatives to Laboratory Animals33: 261–287.
11.
Danish Ministry of the Environment (2013) Evaluation of Health Hazards by Exposure to Ethylene Glycol and Proposal of a Health-Based Quality Criterion for Ambient Air. Copenhagen: The Danish Environmental Protection Agency.
12.
EdwardsSWTanYMVilleneuveDL, et al. (2016). Adverse outcome pathways—organizing toxicological information to improve decision making. Journal of Pharmacology and Experimental Therapeutics356: 170–181.
13.
EURL-ECVAM (2016) DB-ALM Protocol n°158: Human Cell Line Activation Test (h-CLAT). Ispra, Italy: Joint Research Centre.
14.
European Union (2015) EURL-ECVAM recommendation on the human Cell Line Activation Test (h-CLAT) for skin sensitization testing. Luxembourg: Publications Office of the European Union.
15.
GeierJLessmannHCevikN, et al. (2016) Patch testing with didecylmethylammonium chloride. Contact Dermatitis74: 373–384.
16.
GerberickGFRyanCAKernPS, et al. (2005) Compilation of historical local lymph node data for evaluation of skin sensitization alternative method. Dermatitis16: 157–202.
17.
HahnSSchneiderKGartiserS, et al. (2010) Consumer exposure to biocides—identification of relevant sources and evaluation of possible health effects. Environmental Health9: 7.
18.
HartungTBallsMBardouilleC, et al. (2002) Good cell culture practice: ECVAM good cell culture practice task force report 1. Alternatives to Laboratory Animals30: 407–414.
19.
KimMKKimKBYoonKS, et al. (2018) IL-1α and IL-1β as alternative biomarkers for risk assessment and the prediction of skin sensitization potency. Journal of Toxicology and Environmental Health A81: 830–843.
20.
KimHMKwonJTKwanDY, et al. (2014) Inhalation Toxicity Screening Study of Chemical Mixture (I). NIER-RP2014-220. Incheon: National Institute of Environmental Research.
21.
KimYSLeeSBLimCH (2017) Effects of didecyldimethylammonium chloride (DDAC) on Sprague-Dawley rats after 13 weeks of inhalation exposure. Toxicological Research33: 7–14.
22.
KimHRLeeKHParkCW, et al. (2016) Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses. Archives of Toxicology90: 617–632.
23.
KwonDYKimHMKimEJ, et al. (2016) Acute pulmonary toxicity and inflammation induced by combined exposure to didecyldimethylammonium chloride and ethylene glycol in rats. Journal of Toxicological Sciences41: 17–24.
24.
KwonDYKimEJKwonJT, et al. (2015) Ethylene glycol potentiated didecyldimethylammonium chloride toxicity in human bronchial epithelial cells. Molecular and Cellular Toxicology11: 161–166.
25.
LaKindJSMcKennaEAHubnerRP, et al. (1999) A review of the comparative mammalian toxicity of ethylene glycol and propylene glycol. Critical Reviews in Toxicology29: 331–365.
26.
MokarizadehMKafilHSGhanbarzadehS, et al. (2017) Improvement of citral antimicrobial activity by incorporation into nanostructured lipid carriers: a potential application in food stuffs as a natural preservative. Research in Pharmaceutical Sciences12: 409–415.
27.
NepalMRKangYKangMJ, et al. (2018) A β-galactosidase-expressing E. coli culture as an alternative test to identify skin sensitizers and non-sensitizers. Journal of Toxicology and Environmental Health A81: 288–301.
28.
OECD TG 429 (2002) Skin Sensitization: Local Lymph Node Assay. (Adopted: 24 April 2002).
29.
OECD TG 442A (2010) Skin Sensitization: Local Lymph Node Assay: DA. (Adopted: 22 July 2010).
30.
OECD TG 442B (2018) Local lymph Node Assay: BrdU-ELISA or –FCM. (Adopted: 25 June 2018).
31.
OECD TG 442C (2015) In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA). (Adopted: 4 February 2015).
32.
OECD TG 442D (2015) In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method. (Adopted: 4 February 2015).
33.
OECD TG 442E (2017) In Vitro Skin Sensitisation Assays Addressing the Key Event on Activation of Dendritic Cells on the Adverse Outcome Pathway for Skin Sensitisation. (Adopted: 9 October 2017).
34.
ParkDUChoiYYAhnJJ, et al. (2015) Relationship between exposure to household humidifier disinfectants and risk of lung injury: a family-based study. PLoS ONE10(5): e0124610.
RovidaCAlépéeNApiAM, et al. (2015) Integrated testing strategies (ITS) for safety assessment. Alternatives to Animal Experimentation32: 25–40.
37.
ShaneHLLukomskaEAndersonSE (2019) Topical application of the quaternary ammonium compound didecyldimethylammonium chloride activates type-2 innate lymphoid cells and initiate a mixed-type allergic response. Toxicological Sciences168: 508–518.
38.
StricklandJZangQKleinstreuerN, et al. (2016) Integrated decision strategies for skin sensitization hazard. Journal of Applied Toxicology36: 1150–1162.
39.
TakenouchiOFukuiSOkamotoK, et al. (2015) Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals. Journal of Applied Toxicology35: 1318–1332.
